Abu Dhabi, UAE – December 2023 – At COP28, the Abu Dhabi Public Health Centre (ADPHC), Department of Health – Abu Dhabi (DoH), AstraZeneca, and SEHA have signed a Memorandum of Understanding (MoU) to decarbonize the Emirate’s healthcare ecosystem. The strategic partnership aims to address the impact of chronic kidney disease (CKD) and respiratory diseases on healthcare systems and the environment. The collaboration will focus on reducing healthcare-related emissions, designing eco-friendly facilities, adopting efficient care delivery methods, and using medical equipment wisely. The signing took place at COP28, the largest annual climate conference in the world.
H.E. Dr. Omniyat Al Hajeri, Executive Director of the Community Health Sector at the Abu Dhabi Public Health Centre (ADPHC), stated: “COP28 represents a great opportunity for collectively working on building a better future. At ADPHC, we understand how climate change can affect the health of the community. That is why this collaboration with AstraZeneca and our partners in Abu Dhabi underscores the importance of tackling issues such as the decarbonisation of the healthcare sector, to ensure the health and well-being of the community, today, and for generations to come. All entities will be working towards reducing the sector’s carbon footprint and exploring alternative and more sustainable approaches.”
Dr. Marwan Al Kaabi, Group Chief of Critical Infrastructure and Response at PureHealth, said: “As the largest healthcare network in the Middle East, PureHealth has a responsibility to lead the way in promoting environmental sustainability within our industry. Through this initiative with the Abu Dhabi Public Health Centre and AstraZeneca, we hope to decarbonise the healthcare ecosystem in the Emirate of Abu Dhabi. In line with the overall vision of PureHealth, we are committed to forging alliances to inspire healthcare entities and businesses in the country to act towards reducing the sector’s environmental footprint and encouraging energy conservation practices.”
Sameh El Fangary, Country President for the GCC at AstraZeneca added: “Our partnership with ADPHC and SEHA, announced at COP28, will have a positive impact on the clinical, societal, and environmental aspects of chronic kidney diseases and will showcase how Abu Dhabi is unique in taking necessary public policy actions that result from scientific-based research initiatives.
The strategic partnership between ADPHC, AstraZeneca, and SEHA is part of their participation at COP28. The comprehensive 12-day program hosted by DoH and ADPHC focused on healthcare, climate change, and sustainability. The program provided a platform for experts and partners from the UAE and around the world to engage in panel discussions, meetings, presentations, and collaborative conversations.
